#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13494	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2133	622.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1461	1461	C	720	C	697	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13494	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2133	622.9	0	HET	.	.	.	C1525T	.	1525	1525	C	1802	1802	C	674	C,T	495,152	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	515	24464	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3515	686.7	0	.	n	.	0	A20C	SNP	20	20	A	345	345	C	463	C,A	426,24	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	515	24464	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3515	686.7	0	.	n	.	0	T695C	SNP	695	695	T	1020	1020	C	770	C,T	742,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	515	24464	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3515	686.7	0	.	n	.	0	A1638G	SNP	1638	1638	A	1963	1963	G	777	G,T	756,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	515	24464	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3515	686.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2296	2296	C	779	C	750	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	515	24464	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3515	686.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2370	2370	A	797	A	770	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	515	24464	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3515	686.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2922	2922	C	702	C	679	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	515	24464	23S	2890	77	100.0	23S.l15.c4.ctg.2	141	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1668	folP	855	855	100.0	folP.l15.c4.ctg.1	1666	99.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1134	1136	AGC	187;188;190	A;G;C	181;184;187	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4726	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3364	138.2	1	SNP	p	S91F	1	.	.	271	273	TTC	591	593	TTC	164;164;164	T;T;C	159;160;159	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4726	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3364	138.2	1	SNP	p	D95G	1	.	.	283	285	GGC	603	605	GGC	165;167;168	G;G;C	158;160;160	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4726	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3364	138.2	1	SNP	p	G95N	0	.	.	283	285	GGC	603	605	GGC	165;167;168	G;G;C	158;160;160	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1454	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1384	103.4	0	.	p	.	0	F184L	NONSYN	550	552	TTC	940	942	TTG	165;163;164	T;T;G,C	161;160;157,3	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	1454	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1384	103.4	1	SNP	p	G45D	0	.	.	133	135	GGC	523	525	GGC	167;167;166	G;G;C,A	163;163;165,1	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	768	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	900	83.8	0	.	n	.	0	A197.	DEL	197	197	A	501	501	A	187	A	180	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4170	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2889	141.8	1	SNP	p	D86N	0	.	.	256	258	GAC	506	508	GAC	160;161;162	G;A,C;C	155;150,1;156	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4170	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2889	141.8	1	SNP	p	R87W	0	.	.	259	261	CGT	509	511	CGT	165;164;163	C;G;T,G	159;158;156,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4170	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2889	141.8	1	SNP	p	R87I	0	.	.	259	261	CGT	509	511	CGT	165;164;163	C;G;T,G	159;158;156,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4170	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2889	141.8	1	SNP	p	S87R	1	.	.	259	261	CGT	509	511	CGT	165;164;163	C;G;T,G	159;158;156,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4170	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2889	141.8	1	SNP	p	S88P	0	.	.	262	264	TCC	512	514	TCC	162;162;163	T;C;C,T	155;155;158,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3516	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2716	128.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1631	1633	GGC	165;165;162	G;G;C	160;158;157	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3454	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2440	137.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1286	1288	GCA	191;194;198	G,C;C;A,C	185,1;188;190,2	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3454	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2440	137.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1289	1291	ATC	198;198;196	A;T;C,G	194;192;190,2	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3454	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2440	137.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1301	1303	GTG	198;195;199	G;T,G;G	193;187,1;191	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3454	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2440	137.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1301	1303	GTG	198;195;199	G;T,G;G	193;187,1;191	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3454	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2440	137.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1805	1807	ACC	140;141;140	A;C;C	130;135;134	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3454	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2440	137.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1859	1861	GCG	147;149;150	G,A;C,G;G	139,1;127,1;141	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3454	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2440	137.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1859	1861	GCG	147;149;150	G,A;C,G;G	139,1;127,1;141	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3454	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2440	137.9	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1982	1984	AGC	133;134;131	A,G;G;C,T	126,2;129;122,2	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3454	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2440	137.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1991	1993	GGC	125;123;123	G,A;G;C	119,2;120;119	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3454	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2440	137.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2009	2011	CCG	101;105;101	C,G;C,G;G	84,3;89,1;86	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5234	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3259	158.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1664	1666	CCG	175;175;177	C;C,T;G	164;164,1;165	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2068	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1742	116.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	522	522	C	142	C	133	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2494	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1319	181.7	0	.	p	.	0	N38E	NONSYN	112	114	AAT	249	251	GAA	216;217;220	G;A;A	209;211;213	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2494	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1319	181.7	0	.	p	.	0	N134D	NONSYN	400	402	AAT	537	539	GAT	184;183;184	G,A;A;T	173,4;178;179	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2494	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1319	181.7	0	.	p	.	0	P175S	NONSYN	523	525	CCA	660	662	TCA	179;181;180	T;C;A	169;173;172	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2494	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1319	181.7	0	.	p	.	0	A218V	NONSYN	652	654	GCC	789	791	GTC	189;190;194	G,A;T;C	179,3;180;186	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2494	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1319	181.7	0	.	p	.	0	F222S	NONSYN	664	666	TTT	801	803	TCT	189;187;182	T;C,T;T,C	185;179,7;180,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2494	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1319	181.7	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1011	1013	ACT	195;195;197	A;C;T	179;185;189	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2494	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1319	181.7	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1119	1121	GCA	205;203;206	G;C,A;A,T	198;192,4;198,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2494	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1319	181.7	1	SNP	p	G120K	1	.	.	358	360	AAG	495	497	AAG	175;175;179	A;A;G	171;173;177	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2494	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1319	181.7	1	SNP	p	A121D	1	.	.	361	363	GAC	498	500	GAC	181;182;182	G,A;A;C	173,5;180;178	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2494	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1319	181.7	1	SNP	p	D121N	0	.	.	361	363	GAC	498	500	GAC	181;182;182	G,A;A;C	173,5;180;178	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8780	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4747	182.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	976	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	969	99.1	1	SNP	p	V57M	1	.	.	169	171	ATG	500	502	ATG	188;190;193	A;T;G	182;183;183	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
